As of the latest Form 4 filed Jun 15, 2026.
What Elevance Health Inc insiders — officers, directors and 10% owners — have bought and sold in their own stock, straight from their SEC Form 4 filings. Values are shares × the reported transaction price where both are disclosed.
Buys plotted up, sells down; bar height is the disclosed dollar value (shares × reported price). Our Form 4 history is only complete from mid-2026, so early months are sparse — the series fills in as more filings land. Open-market purchases and sales only.
Newest filing first — the 20 most recent filings for ELV.
| Filed | Trade date | Insider | Transaction | Shares | Price | Value | 10b5-1 | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-06-15 | 2026-06-12 | Penczek Ronald W CAO & Controller | SSale | −369.00 | $403.16 | $149K | No | Form 4 ↗ |
| 2026-06-12 | 2026-06-11 | Dixon Robert L JR Director | SSale | −151.00 | $401.77 | $60.7K | No | Form 4 ↗ |
| 2026-05-20 | 2026-05-19 | Penczek Ronald W CAO & Controller | SSale | −1.53K | $403.13 | $617K | No | Form 4 ↗ |
| 2026-05-20 | 2026-05-19 | Penczek Ronald W, CAO & Controller | MExercise | +877.00 | $311.48 | $273K | No | Form 4 ↗ |
| 2026-05-20 | 2026-05-19 | Penczek Ronald W, CAO & Controller | MExercise | +654.00 | $271.27 | $177K | No | Form 4 ↗ |
| 2026-05-15 | 2026-05-13 | Jallal Bahija Director | AAward | +563.00 | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-05-15 | 2026-05-13 | Neri Antonio F Director | AAward | +563.00 | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-05-15 | 2026-05-13 | STRABLE-SOETHOUT DEANNA D Director | AAward | +563.00 | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-05-15 | 2026-05-13 | DeVore Susan D. Director | AAward | +563.00 | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-05-15 | 2026-05-13 | Dixon Robert L JR Director | AAward | +563.00 | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-05-15 | 2026-05-13 | SCHULMAN AMY W Director | AAward | +563.00 | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-05-15 | 2026-05-13 | Schneider Ryan M. Director | AAward | +563.00 | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-05-15 | 2026-05-13 | PERU RAMIRO G Director | AAward | +563.00 | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-05-15 | 2026-05-13 | COLLIS STEVEN H Director | AAward | +563.00 | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-05-15 | 2026-05-13 | HAY LEWIS III Director | AAward | +563.00 | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-23 | 2026-03-12 | SCHULMAN AMY W Director | SSale | −26.00 | $287.50 | $7.47K | No | Form 4 ↗ |
| 2026-03-09 | 2026-03-06 | Kendrick Charles Morgan JR EVP & President, Commercial | SSale | −3.20K | $284.92 | $911K | No | Form 4 ↗ |
| 2026-03-06 | 2026-03-05 | COLLIS STEVEN H Director | PPurchase | +3.00K | $289.84 | $870K | No | Form 4 ↗ |
| 2026-02-03 | 2026-02-02 | Craig Ryan R EVP & Chief HR Officer | FTax | −279.00 | $341.83 | $95.4K | No | Form 4 ↗ |
| 2026-02-03 | 2026-02-02 | SCHULMAN AMY W Director | AAward | +218.00 | $0.00 | $0.00 | No | Form 4 ↗ |
Insiders — a company’s officers, directors and holders of more than 10% of its stock — must report any trade in that stock to the SEC on a Form 4 within two business days. Each row here is one transaction from those filings.
The transaction code tells you what happened: Purchase (P) and Sale (S) are open-market trades — the ones markets watch most; Award (A) is a granted stock or unit, Option exercise (M) converts options into shares, and Gift (G) is a transfer for no consideration. Awards, exercises and gifts are largely compensation or administrative, not a directional bet.
One caveat on sales: many are made under a Rule 10b5-1 plan scheduled months in advance, so a sale is not automatically a bearish signal. Insider activity is a noisy input — read it alongside the filings, not on its own.
See also ELV’s full analysis or the market-wide insider trading feed. The tabs above jump to ELV’s other SEC data.
Source: SEC Form 4 filings for ELV, parsed from EDGAR. Transaction prices are as reported in the filing — SEC public-domain data, not market quotes. Values are shares × reported price where both are disclosed; grants and gifts often carry no price. A delayed record of what insiders reported, not a live position or a recommendation.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.